1
results found
Non-small cell lung cancer (NSCLC) patients carrying HER2 20ins exon 20 insertion (HER2 20ins) are poorly respond to conventional therapies and pan HER inhibitors. Trastuzumab Deruxtecan (T-DXd) has b...
HER2 (ERBB2)
NSCLC
Deruxtecan (T-DXd
DS-8201)
Genomic instability
Immune microenvironment
SinoXiv